Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W A Breeman

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
Life Sciences|January 1, 1991
[111In-DTPA-D-Phe1]-octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors: synthesis, radiolabeling and in vitro validationW H Bakker, R Albert, C Bruns, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 26, 2001
Tumor response after [(90)Y-DOTA(0),Tyr(3)]octreotide radionuclide therapy in a transplantable rat tumor model is dependent on tumor sizeM de Jong, W A Breeman, B F Bernard, et al.
Nuclear Medicine and Biology|January 15, 1998
Effects of ligand priming and multiple-dose injection on tissue uptake of 111In-pentetreotide in ratsW A Breeman, M de Jong, B F Bernard, et al.
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)|September 1, 1996
Studies on radiolabeled somatostatin analogues in rats and in patientsW A Breeman, W H Bakker, M De Jong, et al.
Proceedings of the Association of American Physicians|January 20, 1999
Internalization of [DOTA degrees,125I-Tyr3]Octreotide by somatostatin receptor-positive cells in vitro and in vivo: implications for somatostatin receptor-targeted radio-guided surgeryL J Hofland, W A Breeman, E P Krenning, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 1, 1993
Hepatobiliary handling of iodine-125-Tyr3-octreotide and indium-111-DTPA-D-Phe1-octreotide by isolated perfused rat liverM de Jong, W H Bakker, W A Breeman, et al.
Lancet (London, England)|February 4, 1989
Localisation of endocrine-related tumours with radioiodinated analogue of somatostatinE P Krenning, W H Bakker, W A Breeman, et al.
International Journal of Cancer|September 20, 2000
Evaluation of a radiolabelled cyclic DTPA-RGD analogue for tumour imaging and radionuclide therapyP M van Hagen, W A Breeman, H F Bernard, et al.
Anticancer Research|May 6, 1998
Tissue distribution and metabolism of radioiodinated DTPA0, D-Tyr1 and Tyr3 derivatives of octreotide in ratsW A Breeman, M de Jong, B Bernard, et al.
Italian Journal of Gastroenterology and Hepatology|December 22, 1999
Scintigraphy and radionuclide therapy with [indium-111-labelled-diethyl triamine penta-acetic acid-D-Phe1]-octreotideE P Krenning, R Valkema, P P Kooij, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Life Sciences|January 1, 1991
[111In-DTPA-D-Phe1]-octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors: synthesis, radiolabeling and in vitro validationW H Bakker, R Albert, C Bruns, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 26, 2001
Tumor response after [(90)Y-DOTA(0),Tyr(3)]octreotide radionuclide therapy in a transplantable rat tumor model is dependent on tumor sizeM de Jong, W A Breeman, B F Bernard, et al.
Nuclear Medicine and Biology|January 15, 1998
Effects of ligand priming and multiple-dose injection on tissue uptake of 111In-pentetreotide in ratsW A Breeman, M de Jong, B F Bernard, et al.
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)|September 1, 1996
Studies on radiolabeled somatostatin analogues in rats and in patientsW A Breeman, W H Bakker, M De Jong, et al.
Proceedings of the Association of American Physicians|January 20, 1999
Internalization of [DOTA degrees,125I-Tyr3]Octreotide by somatostatin receptor-positive cells in vitro and in vivo: implications for somatostatin receptor-targeted radio-guided surgeryL J Hofland, W A Breeman, E P Krenning, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 1, 1993
Hepatobiliary handling of iodine-125-Tyr3-octreotide and indium-111-DTPA-D-Phe1-octreotide by isolated perfused rat liverM de Jong, W H Bakker, W A Breeman, et al.
Lancet (London, England)|February 4, 1989
Localisation of endocrine-related tumours with radioiodinated analogue of somatostatinE P Krenning, W H Bakker, W A Breeman, et al.
International Journal of Cancer|September 20, 2000
Evaluation of a radiolabelled cyclic DTPA-RGD analogue for tumour imaging and radionuclide therapyP M van Hagen, W A Breeman, H F Bernard, et al.
Anticancer Research|May 6, 1998
Tissue distribution and metabolism of radioiodinated DTPA0, D-Tyr1 and Tyr3 derivatives of octreotide in ratsW A Breeman, M de Jong, B Bernard, et al.
Italian Journal of Gastroenterology and Hepatology|December 22, 1999
Scintigraphy and radionuclide therapy with [indium-111-labelled-diethyl triamine penta-acetic acid-D-Phe1]-octreotideE P Krenning, R Valkema, P P Kooij, et al.
Pageof 6